Find grants for Education Services

Total Dollars Available
$ 100 Trillion

Add Your Heading Text Here

All Categories Agriculture & Farming Performing Arts & Culture Small Business Community Services, Economic Development & Municipal Consumer Protection Disaster Relief, EMS & Homeland Security Education Services Employment, Labor and Training Energy Environment Food and Nutrition Health Housing Humanities Income Security and Social Services Information and Statistics Infrastructure Investment and Jobs Act (IIJA) Law, Justice and Legal Services Natural Resources Opportunity Zone Benefits Other Regional Development Science and Technology Transportation
Advanced Filters Clear

Showing 25 of 127 grants in "Education"

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

Deadline: May 7, 2027

Opportunity Number: PAR-25-272

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.866, 93.396, 93.865

View Grant

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

Deadline: May 7, 2027

Opportunity Number: PAR-25-279

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.396, 93.866, 93.865, 93.286

View Grant

The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-292

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.866, 93.361, 93.393, 93.307, 93.399, 93.396, 93.279, 93.242

View Grant

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

Deadline: May 7, 2027

Opportunity Number: PAR-26-001

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.307, 93.273, 93.399, 93.121, 93.279, 93.313

View Grant

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Deadline: October 8, 2027

Opportunity Number: PAR-25-248

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: October 8, 2027

Status: Posted

CFDA Numbers: 93.393

View Grant

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)

Deadline: January 7, 2028

Opportunity Number: PAR-25-148

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.396, 93.865, 93.866, 93.393, 93.395, 93.173, 93.394, 93.172, 93.273, 93.242, 93.279, 93.839, 93.867, 93.840, 93.837, 93.361, 93.233, 93.838, 93.399

View Grant

Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)

Deadline: January 7, 2027

Opportunity Number: PAR-25-235

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.242, 93.879

View Grant

NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

Deadline: October 14, 2027

Opportunity Number: PAR-25-135

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: October 14, 2027

Status: Posted

CFDA Numbers: 93.398

View Grant

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Deadline: November 18, 2027

Opportunity Number: RFA-DA-26-034

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: November 18, 2027

Status: Posted

CFDA Numbers: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838

View Grant

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Deadline: January 7, 2027

Opportunity Number: PAR-25-069

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

View Grant

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-243

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

View Grant

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027

Opportunity Number: PAR-25-070

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

View Grant

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Deadline: November 16, 2027

Opportunity Number: PAR-25-244

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.393

View Grant

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-124

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

View Grant

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Deadline: November 17, 2026

Opportunity Number: PAR-25-096

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 17, 2026

Status: Posted

CFDA Numbers: 93.393, 93.121, 93.172, 93.866

View Grant

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Deadline: November 6, 2026

Opportunity Number: PAR-25-095

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 6, 2026

Status: Posted

CFDA Numbers: 93.172, 93.393, 93.866, 93.121

View Grant

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Deadline: May 4, 2028

Opportunity Number: PA-25-168

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: May 4, 2028

Status: Posted

CFDA Numbers: 93.273, 93.865, 93.279, 93.172, 93.313, 93.351, 93.867, 93.310, 93.846, 93.838, 93.847, 93.113, 93.853, 93.397, 93.855, 93.213, 93.361, 93.286, 93.233, 93.242, 93.840, 93.399, 93.398, 93.837, 93.173, 93.121, 93.839, 93.866, 93.396, 93.859

View Grant

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027

Opportunity Number: PAR-25-256

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.172

View Grant

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Deadline: February 8, 2027

Opportunity Number: RFA-MH-26-170

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: February 8, 2027

Status: Posted

CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279

View Grant

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Deadline: November 5, 2026

Opportunity Number: PAR-25-255

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: November 5, 2026

Status: Posted

CFDA Numbers: 93.399, 93.242, 93.172

View Grant

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Deadline: September 7, 2028

Opportunity Number: PA-25-253

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: September 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393

View Grant

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Deadline: January 7, 2027

Opportunity Number: PAR-25-167

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.393

View Grant

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Deadline: January 7, 2027

Opportunity Number: PAR-25-081

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393, 93.399, 93.394, 93.395

View Grant

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PA-25-172

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393

View Grant

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Deadline: January 7, 2027

Opportunity Number: PAR-25-221

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.396, 93.273

View Grant
×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.